We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUBY
6351
DELISTED
Rubius Therapeutics, Inc
RUBY
$33K ﹤0.01%
76,330
-34,770
-31% -$26.1K
AIEQ icon
6352
Amplify AI Powered Equity ETF
AIEQ
$125M
$32K ﹤0.01%
1,102
-200
-15% -$6.61K
KEEL
6353
Keel Infrastructure Corp
KEEL
$2.04B
$32K ﹤0.01%
31,027
-119,983
-79% -$164K
COMB icon
6354
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$150M
$32K ﹤0.01%
1,124
-320
-22% -$9.75K
CRVS icon
6355
Corvus Pharmaceuticals
CRVS
$1.27B
$32K ﹤0.01%
39,317
-10,031
-20% -$9.57K
HOOK
6356
DELISTED
HOOKIPA Pharma
HOOK
$32K ﹤0.01%
2,418
-6,242
-72% -$95.8K
LGVN
6357
Longeveron
LGVN
$22M
$32K ﹤0.01%
868
+738
+568% +$40.8K
MBCE
6358
Monarch Blue Chips Elite Index ETF
MBCE
$205M
$32K ﹤0.01%
1,515
ORIO
6359
Orion Digital Corp
ORIO
$21.1M
$32K ﹤0.01%
11,929
-21,040
-64% -$66.4K
VTVT icon
6360
vTv Therapeutics
VTVT
$122M
$32K ﹤0.01%
836
GXDW
6361
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.52M
$32K ﹤0.01%
1,248
-250
-17% -$7.56K
NGE
6362
DELISTED
Global X MSCI Nigeria ETF
NGE
$32K ﹤0.01%
4,109
-1,000
-20% -$8.62K
SVFAU
6363
DELISTED
SVF Investment Corp. Unit
SVFAU
$32K ﹤0.01%
3,175
-8,139
-72% -$80.8K
HAACU
6364
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$32K ﹤0.01%
3,251
-2,900
-47% -$28.8K
CPIX icon
6365
Cumberland Pharmaceuticals
CPIX
$118M
$31K ﹤0.01%
12,894
+10,234
+385% +$24.1K
EJAN icon
6366
Innovator Emerging Markets Power Buffer ETF January
EJAN
$148M
$31K ﹤0.01%
1,250
FTHI icon
6367
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.48B
$31K ﹤0.01%
1,698
+44
+3% +$899
FXNC icon
6368
First National Corp
FXNC
$291M
$31K ﹤0.01%
1,966
+1,653
+528% +$28.4K
OPTT icon
6369
Ocean Power Technologies
OPTT
$55.4M
$31K ﹤0.01%
37,467
-35,610
-49% -$33.2K
SACH
6370
Sachem Capital Corp
SACH
$37.6M
$31K ﹤0.01%
9,309
SBFG icon
6371
SB Financial Group
SBFG
$171M
$31K ﹤0.01%
1,820
-494
-21% -$8.53K
SQEW
6372
DELISTED
LeaderShares Equity Skew ETF
SQEW
$31K ﹤0.01%
+1,176
New +$34.6K
NAGE
6373
Niagen Bioscience
NAGE
$241M
$31K ﹤0.01%
25,411
-129,871
-84% -$209K
SPRB
6374
Spruce Biosciences
SPRB
$143M
$31K ﹤0.01%
309
-500
-62% -$69.9K
AWH
6375
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$31K ﹤0.01%
5,452
-5,104
-48% -$54.9K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.